Panacea Biotec Share Price

Panacea Biotec Share Price

NSE: PANACEABIO
|
Pharmaceuticals
|
S Cap
₹ 372.00
+₹4.85 (1.32%)
1D
Last updated 17 Sep, 2026, 15:52 IST

Panacea Biotec Share Price Today

As of 17 Sep 2026, Panacea Biotec share price is ₹372.00. The stock opened at ₹373.00, compared to its previous close of ₹367.15. During today's trading session, Panacea Biotec share price moved in the range of ₹367.15 to ₹383.35, with an average price of ₹375.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹292.40 and a high of ₹647.00. On the performance front, Panacea Biotec share price has increased by 17.28% over the last six months and is down 19.02% on a year-on-year basis.

₹367.15
1.32% up today
₹383.35
1D LOW
1D HIGH

Panacea Biotec Returns Calculator

Circuit
L
H
₹330.45
₹403.85
52-week
L
H
₹292.40
₹647.00

About Panacea Biotec

Panacea Biotec Share Price
ISIN
INE922B01023
Sector Market Cap
₹ 2,251.88 Cr

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.

Panacea Biotec Financial Highlights

  • Revenue: Panacea Biotec reported revenue of ₹656.67 crore in FY26 vs ₹579.75 crore in FY25. It showed an increase of 13.27% on a yearly basis.
  • Operating Profit: Panacea Biotec reported an operating loss of ₹7.37 crore in FY26 vs ₹7.95 crore in FY25. It showed an increase of 7.30% on a year-on-year basis.
  • Net Profit: Panacea Biotec reported a net loss of ₹7.16 crore in FY26 vs ₹8.72 crore in FY25. It showed an increase of 17.89% on a yearly basis.

Panacea Biotec Quarterly Result Highlights

  • Panacea Biotec reported revenue of ₹203.81 crore in Jun 2026, compared with ₹169.30 crore in Mar 2026, representing an increase of 20.38% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported an operating profit of ₹3.57 crore in Jun 2026, compared with ₹1.25 crore in Mar 2026, representing an increase of 385.60% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported a profit of ₹2.20 crore in Jun 2026, compared with ₹1.00 crore in Mar 2026, reflecting an increase of 320.00% on a QoQ basis.
  • The earnings per share (EPS) of Panacea Biotec stood at ₹1.37 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.48%
FII
2.31%
Other DII
2.25%
Retail and other
22.96%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.06%
Dec 20251.36%
Mar 20261.60%
Jun 20262.31%
Mkt Cap Cr
2,251.88
P/E
-251.82
P/B
2.70
ROE
-2.93%
D/E
0.93
ROCE
-2.42%
Div. Yield
0.00%
EPS(TTM)
-4.88
Turnover
0.51
EV/EBITDA
79.10
Net Margin
-7.23%
Op. Margin
0.04%
ROA
-0.71%
Quick Ratio
0.55
Curr. Ratio
1.07
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Panacea Biotec has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Panacea Biotec appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Panacea Biotec revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,44,717.0036.705.3213.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,44,223.0083.5014.5715.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,83,453.0085.0921.8225.49%1.6913.85%222.760.70%0.4958.70
Cipla1,09,849.0032.733.1911.27%0.0014.95%423.360.96%0.4543.52
Zydus Lifesciences1,10,224.0024.004.0718.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs1,02,984.0094.4519.4316.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories95,591.8030.032.5111.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma94,419.5025.452.499.25%0.1911.76%394.820.25%0.3841.58
Mankind Pharma92,852.5044.915.7011.74%0.3413.13%396.980.04%0.4449.37
Lupin93,611.5016.864.1723.76%0.0424.88%659.000.88%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Panacea Biotec Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹559.09₹559.17₹459.95₹661.23
Other Income₹20.66₹25.80₹51.66₹10.97
Total Revenue₹579.75₹584.96₹511.61₹672.20
Total Expenses₹623.70₹619.52₹601.47₹899.05
Profit Before Tax-₹7.95₹1.48₹12.81₹1,449.36
Tax₹0.77₹2.98₹46.55₹371.02
Profit After Tax-₹8.72-₹1.51-₹33.75₹1,078.33
EPS - Basic-₹1.37-₹0.19-₹5.43₹176.05
EPS - Diluted-₹1.37-₹0.19-₹5.43₹176.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹7.95₹1.48₹12.81₹1,449.36
Income before WC changes-₹17.82-₹7.28-₹83.06-₹5.61
Change in Assets-₹101.58-₹0.85-₹13.27-₹73.14
Change in Liabilities₹93.00₹10.54-₹323.65₹374.00
Change in WC-₹8.58₹9.69-₹336.91₹300.86
Cash flow from Operations-₹27.37-₹0.10-₹422.45-₹108.45
Cash flow from Investing₹64.98₹10.23₹430.33₹1,282.57
Cash flow from Financing-₹2.66-₹2.81-₹18.37-₹1,175.85
Total Cash Flow₹34.95₹7.32-₹10.49-₹1.73
Cash (Start of the year)₹47.17₹39.85₹50.35₹52.08
Cash (End of the year)₹82.13₹47.17₹39.85₹50.34

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹744.57₹755.49₹708.85₹808.31
Current Assets₹545.18₹485.18₹562.32₹950.56
Total Assets₹1,289.75₹1,240.67₹1,271.17₹1,758.87
Current Liabilities₹366.99₹308.83₹329.73₹776.37
Net Current Asset₹178.19₹176.35₹232.59₹174.19
Non-Current Liabilities₹92.14₹93.61₹101.32₹108.85
Equity Capital₹830.62₹838.23₹840.11₹873.66
Total Equity & Liabilities₹1,289.75₹1,240.67₹1,271.17₹1,758.87

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹309.86₹359.60₹257.07₹235.50
Other Income₹16.62₹24.91₹34.44₹12.57
Total Revenue₹326.47₹384.51₹291.50₹248.07
Total Expenses₹352.53₹380.31₹354.25₹341.65
Profit Before Tax-₹26.06₹4.21-₹62.75-₹93.58
Tax-₹10.83₹0.66₹24.79₹0.00
Profit After Tax-₹15.23₹3.55-₹87.54-₹93.58
EPS - Basic-₹2.49₹0.58-₹14.29-₹15.28
EPS - Diluted-₹2.49₹0.58-₹14.29-₹15.28

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹43.88-₹26.06₹4.21-₹62.75
Income before WC changes-₹1.88₹3.87₹30.95-₹52.32
Change in Assets-₹6.73-₹50.40₹0.78₹5.19
Change in Liabilities-₹27.26₹51.58₹3.22₹37.48
Change in WC-₹33.99₹1.18₹4.00₹42.67
Cash flow from Operations-₹40.17₹3.94₹33.07-₹10.74
Cash flow from Investing-₹18.53-₹60.60-₹46.80₹2.41
Cash flow from Financing₹22.54₹90.07₹12.82₹9.01
Total Cash Flow-₹36.16₹33.41-₹0.91₹0.67
Cash (Start of the year)₹38.50₹5.09₹6.01₹5.33
Cash (End of the year)₹2.42₹38.50₹5.09₹6.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹575.74₹570.30₹524.77₹513.01
Current Assets₹293.73₹183.49₹199.13₹248.83
Total Assets₹869.47₹753.79₹723.90₹761.83
Current Liabilities₹351.40₹249.14₹250.85₹246.76
Net Current Asset-₹57.67-₹65.65-₹51.72₹2.07
Non-Current Liabilities₹204.10₹175.51₹147.40₹99.98
Equity Capital₹313.97₹329.14₹325.65₹415.09
Total Equity & Liabilities₹869.47₹753.79₹723.90₹761.83
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
372
82
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 82
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
34.46
Neutral
ATR (14)
15.07
Neutral
STOCH(9,6)
13.67
Bullish
STOCH RSI (14)
13.03
Bullish
ADX(9)
19.22
Bullish
UO(9)
41.16
Neutral
ROC(12)
-7.17
Bearish
WillR(14)
-88.95
Bullish
Period
Simple value
Exponential vaue
5D
384.6
380.02
10D
384.59
384.8
20D
392.51
393.36
50D
432.77
418.95
100D
448.84
425.87
Volume trend — traded volume by day
17 Sep0L
16 Sep1L
15 Sep2L
11 Sep0L
10 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Panacea Biotec Share Price
Panacea Biotec
Pharmaceuticals
Add Stock
Add Another

Panacea Biotec Share Price FAQs

Panacea Biotec share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837